Deborah A Levine1, Anthony J Perkins2,3, Jason J Sico4,5, Laura J Myers3,6, Michael S Phipps6, Ying Zhang7, Dawn M Bravata2,3,6. 1. University of Michigan Departments of Internal Medicine and Neurology, and Cognitive Health Services Research Program, Ann Arbor (D.A.L.). 2. Department of Internal Medicine, Indiana University School of Medicine, Indianapolis (A.J.P., D.M.B.). 3. Department of Veterans Affairs Health Services Research and Development Precision Monitoring to Transform Care Quality Enhancement Research Initiative, Indianapolis, IN (A.J.P., L.J.M., D.M.B.). 4. Department of Neurology, VA Connecticut Healthcare System, West Haven, CT (J.J.S.). 5. Yale School of Medicine Departments of Neurology and Internal Medicine, New Haven, CT (J.J.S.). 6. VA HSR&D Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, Indianapolis, IN (L.J.M., M.S.P., D.M.B.). 7. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha (Y.Z.).
Abstract
Background and Purpose: We determined the association between hospital factors, performance on transient ischemic attack (TIA) process measures, and 90-day ischemic stroke incidence. Methods: Longitudinal analysis of retrospectively obtained data on 9168 veterans ≥18 years with TIA presenting to the emergency department or inpatient unit at 69 Veterans Affairs hospitals with ≥10 eligible patients per year in fiscal years 2015 to 2018. Process measures were high/moderate potency statin within 7 days of discharge, antithrombotic by day 2, and hypertension control (<140/90 mm Hg) at 90 days. The outcome was 90-day stroke incidence. Results: During the 4-year study period, hospitals significantly increased statin use (adjusted odds ratio [aOR] per 1-year increase, 1.24 [95% CI, 1.17–1.32]; P<0.001), whereas neither hypertension control (P=0.44) nor antithrombotic use (P=0.82) improved over time. Hospitals that admitted a higher proportion of TIA patients versus emergency department discharge had significantly greater use of statins (aOR per 10-percentage point increase in the proportion of TIA patients admitted, 1.09 [1.03–1.16]; P=0.003) and antithrombotics (aOR per 10-percentage point increase in TIA patients admitted, 1.14 [1.06–1.23]; P<0.001). Hospitals with higher emergency physician staffing and lower TIA patient volume had greater use of antithrombotics (aOR per 1 full-time physician increase, 1.05 [1.01–1.08]; P=0.008 and aOR per 10-patient decrease in volume, 1.09 [1.01–1.16]; P=0.02). Higher emergency physician staffing was associated with lower 90-day stroke incidence (aOR per 1 full-time physician increase, 0.96 [0.92–0.99]; P=0.02) but other hospital factors were not. Conclusions: Hospitals admitting higher percentages of TIA patients and having higher emergency physician staffing have greater performance on select guideline-concordant process measures for TIA. Higher emergency physician staffing was associated with improved outcomes 90 days after TIA.
Background and Purpose: We determined the association between hospital factors, performance on transient ischemic attack (TIA) process measures, and 90-day ischemic stroke incidence. Methods: Longitudinal analysis of retrospectively obtained data on 9168 veterans ≥18 years with TIA presenting to the emergency department or inpatient unit at 69 Veterans Affairs hospitals with ≥10 eligible patients per year in fiscal years 2015 to 2018. Process measures were high/moderate potency statin within 7 days of discharge, antithrombotic by day 2, and hypertension control (<140/90 mm Hg) at 90 days. The outcome was 90-day stroke incidence. Results: During the 4-year study period, hospitals significantly increased statin use (adjusted odds ratio [aOR] per 1-year increase, 1.24 [95% CI, 1.17–1.32]; P<0.001), whereas neither hypertension control (P=0.44) nor antithrombotic use (P=0.82) improved over time. Hospitals that admitted a higher proportion of TIA patients versus emergency department discharge had significantly greater use of statins (aOR per 10-percentage point increase in the proportion of TIA patients admitted, 1.09 [1.03–1.16]; P=0.003) and antithrombotics (aOR per 10-percentage point increase in TIA patients admitted, 1.14 [1.06–1.23]; P<0.001). Hospitals with higher emergency physician staffing and lower TIA patient volume had greater use of antithrombotics (aOR per 1 full-time physician increase, 1.05 [1.01–1.08]; P=0.008 and aOR per 10-patient decrease in volume, 1.09 [1.01–1.16]; P=0.02). Higher emergency physician staffing was associated with lower 90-day stroke incidence (aOR per 1 full-time physician increase, 0.96 [0.92–0.99]; P=0.02) but other hospital factors were not. Conclusions: Hospitals admitting higher percentages of TIA patients and having higher emergency physician staffing have greater performance on select guideline-concordant process measures for TIA. Higher emergency physician staffing was associated with improved outcomes 90 days after TIA.
Authors: Dawn M Bravata; Laura J Myers; Eric Cheng; Mathew Reeves; Fitsum Baye; Zhangsheng Yu; Teresa Damush; Edward J Miech; Jason Sico; Michael Phipps; Alan Zillich; Jason Johanning; Seemant Chaturvedi; Curt Austin; Jared Ferguson; Bailey Maryfield; Kathy Snow; Susan Ofner; Glenn Graham; Rachel Rhude; Linda S Williams; Greg Arling Journal: Circ Cardiovasc Qual Outcomes Date: 2017-09
Authors: Moira K Kapral; Ruth Hall; Jiming Fang; Peter C Austin; Frank L Silver; David J Gladstone; Leanne K Casaubon; Melissa Stamplecoski; Jack V Tu Journal: Neurology Date: 2016-03-25 Impact factor: 9.910
Authors: Barbara J Homoya; Teresa M Damush; Jason J Sico; Edward J Miech; Gregory W Arling; Laura J Myers; Jared B Ferguson; Michael S Phipps; Eric M Cheng; Dawn M Bravata Journal: J Gen Intern Med Date: 2018-11-27 Impact factor: 5.128
Authors: Peter M Rothwell; Matthew F Giles; Arvind Chandratheva; Lars Marquardt; Olivia Geraghty; Jessica N E Redgrave; Caroline E Lovelock; Lucy E Binney; Linda M Bull; Fiona C Cuthbertson; Sarah J V Welch; Shelley Bosch; Faye C Alexander; Faye Carasco-Alexander; Louise E Silver; Sergei A Gutnikov; Ziyah Mehta Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Pierre Amarenco; Philippa C Lavallée; Julien Labreuche; Gregory W Albers; Natan M Bornstein; Patrícia Canhão; Louis R Caplan; Geoffrey A Donnan; José M Ferro; Michael G Hennerici; Carlos Molina; Peter M Rothwell; Leila Sissani; David Školoudík; Philippe Gabriel Steg; Pierre-Jean Touboul; Shinichiro Uchiyama; Éric Vicaut; Lawrence K S Wong Journal: N Engl J Med Date: 2016-04-21 Impact factor: 91.245
Authors: Lisa M Fleming; Philip Jones; Paul S Chan; Adin-Christian Andrei; Thomas M Maddox; Steven A Farmer Journal: Circ Cardiovasc Qual Outcomes Date: 2015-12-08
Authors: Dawn M Bravata; Laura J Myers; Mathew Reeves; Eric M Cheng; Fitsum Baye; Susan Ofner; Edward J Miech; Teresa Damush; Jason J Sico; Alan Zillich; Michael Phipps; Linda S Williams; Seemant Chaturvedi; Jason Johanning; Zhangsheng Yu; Anthony J Perkins; Ying Zhang; Greg Arling Journal: JAMA Netw Open Date: 2019-07-03